From the Editor

Oct 01, 2011
Pharmaceutical Executive
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Sep 01, 2011
Pharmaceutical Executive
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
Aug 01, 2011
Pharmaceutical Executive
What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders
Jul 01, 2011
Pharmaceutical Executive
More bad ideas on how to manage the healthcare burden are circulating beyond the stakeholders that initiated them
Jun 01, 2011
Pharmaceutical Executive
Now that government payers are turning to pharma to bridge budgetary shortfalls it's best to think long-term
May 01, 2011
Pharmaceutical Executive
What do the Pharm Exec 50 numbers tell us? The dominant theme seems to be one of gradual restructuring toward a post-patent-cliff era.
Apr 01, 2011
Pharmaceutical Executive
A true performance culture has to focus on the mundane as much as the sublime
Apr 01, 2011
Pharmaceutical Executive
Dutch-based DSM N.V. is seeking innovatinve ways to partner through bolstering manufacturing
Mar 01, 2011
Pharmaceutical Executive
Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
Feb 04, 2011
Pharmaceutical Executive
"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety
native1_300x100
lorem ipsum